How much does one month of treatment with tucatinib cost? Long-term cost analysis

Tucatinib is a targeted drug used to treat HER2-positive breast cancer. Although it has not yet been launched in China, it is already sold in some international markets. The price of tucatinib varies widely depending on the strength and source of the drug. For original drugs, the price of 150mg*84 tablets of original drugs in the European market is usually as high as more than 40,000 yuan, and the monthly treatment cost is about 13,000 to 15,000 yuan. For patients who need to use the drug for a long time, the cost is undoubtedly very high, especially when it cannot be purchased directly in China, and patients often need to purchase it through regular overseas channels.

Due to the higher price of original drugs, some patients may choose generic drugs as an alternative. In some countries and regions, generic drugs produced by Lao pharmaceutical factories have been launched, with a specification of 150mg*60 tablets and a price of about more than 2,000 yuan. Compared with original drugs, generic drugs are significantly lower in price, greatly reducing the financial burden on patients. On a monthly basis, the cost of treatment with generic drugs is approximately RMB 600 to RMB 800, which is obviously more affordable. It is worth noting that although generic drugs are basically the same as the original drugs in terms of ingredients, patients still need to pay attention to drug quality and formal channels to ensure drug safety.

The cost of long-term tucatinib will be determined based on the patient's duration of treatment. For some patients with metastatic HER2-positive breast cancer, they may need to rely on this drug for a long time to maintain disease control. Therefore, the economic burden of long-term treatment cannot be ignored. If the patient chooses the original drug, the monthly cost will be between 10,000 and 15,000 yuan. If the treatment lasts for one year, this cost will reach 120,000 to 180,000 yuan. For patients who choose generic drugs, the cost is significantly reduced. The monthly cost is approximately 600 to 800 yuan, and the annual treatment cost is approximately 7,200 to 9,600 yuan.
To sum up, the cost of tucatinib varies greatly depending on the drug version chosen and the purchase channel. The price of original drugs is higher, and long-term treatment may cause heavy financial pressure on patients, while generic drugs provide more economical treatment options, but their quality and safety still need to be ensured. If reimbursement by medical insurance is not possible, patients should weigh drug options based on their own financial situation and treatment needs, and discuss the best treatment plan with their doctor.
Reference: https://www.tukysa.com/